Nostrum Biodiscovery names Majeed Hosseiney as Chief Executive Officer
In his new role, Hosseiney will be responsible for the oversight and continued growth of NBD's Global Operations
Nostrum Biodiscovery, a Barcelona-based biotechnology company, is thrilled to announce the addition of Majeed Hosseiney to its leadership team as CEO. In his new role, Hosseiney will be responsible for the oversight and continued growth of NBD's Global Operations.
“Majeed brings a unique combination of savvy strategic thinking with high performance operational experience into applied scientific business” said Prof. Modesto Orozco (IRB, Institute for Research in Biomedicine) and Prof. Victor Guallar (BSC, Barcelona Supercomputing Centre), co-founders of Nostrum Biodiscovery. “With his emphasis on company objectives and approach to business transformation, as well as his integrity and engaged leadership style, he is the ideal candidate to take Nostrum Biodiscovery to the next level globally.”
Hosseiney brings over 28 years of experience to his position as CEO and is a global-minded expert in strategy, technology and business transformation. Prior to joining Nostrum Biodiscovery, Hosseiney worked as Chief Strategy Officer and Vice President of Operations for the EMEA region for Elements Global Services and continues to serve as a professor of project management, leadership and ethics at the La Salle business school. Hosseiney also held several managerial positions before his time at the Think It Project, delivering sustainable international projects and supporting major multinational companies including Transcom Worldwide, ADP, Oracle, IBM, Statoil, YARA, Hydro, Telenor, Sony Europe and more.
“Business leadership is constantly evolving and Nostrum Biodiscovery recognizes the necessity of such evolution and transformation in business leadership” Majeed Hosseiney stated. “I'm excited to join Nostrum Biodiscovery's leadership team during such an exciting moment of expansion, combining science, technology, and business, and to work for a company that values diversity, innovation, and real leadership.”
About NBD
Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers.
We provide advanced technologies in Molecular Modelling, with three areas of focus : Drug Discovery, Enzyme Engineering and Nucleic Acids.
Our customer-tailored solutions are based on our state-of-the-art proprietary and 3rd parties software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms.
Nostrum Biodiscovery has clients in more than 12 countries and is currently expanding in Asia, Latin America while strengthening its presence in the US and Europe.